The global biopsy devices market was estimated at USD 2.21 billion in 2022 and it is expected to surpass around USD 4.41 billion by 2032, poised to grow at a CAGR of 7.15% from 2023 to 2032.
Key Pointers
The growing prevalence of cancer worldwide, the presence of untapped opportunities in emerging economies, especially in Asia Pacific, and improving healthcare infrastructure in these regions are among the key trends encouraging industry growth.
The increasing incidence of cancer worldwide is the major factor driving the demand for biopsy devices. For instance, in 2022, an estimated 1.9 million new cancer cases will be diagnosed in the U.S., according to the American Cancer Society. The rising incidence of cancer is encouraging the development of more effective, safe, and advanced biopsy procedures.
Minimally invasive medical procedures offer several advantages, thus bolstering their popularity. Such procedures result in the quicker recovery of patients and are less traumatic. Research results published by manufacturers suggest that minimally invasive surgeries are rapidly replacing invasive surgeries and providing higher patient satisfaction levels.
Spiraling demand for less invasive surgeries and disposable biopsy devices is anticipated to propel the industry's growth. Technologically advanced biopsy guidance systems, such as vacuum-assisted guns, are gaining popularity among patients and healthcare providers. The widening base of the geriatric population and the introduction of cost-effective and advanced devices are anticipated to further boost the growth of the market.
Growing cancer-related spending is triggering the need for effective diagnostic procedures. Government and healthcare regulatory bodies all across the world are constantly engaged in curbing the high costs associated with the treatment of cancer. Primary and secondary healthcare centers in emerging nations are encouraging patients to undergo regular diagnostic examinations. The use of biopsy devices involves a relatively lesser number of hospital visits and therefore, is economically viable.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1.Research Objective
1.2.Scope of the Study
1.3.Definition
Chapter 2. Research Methodology
2.1.Research Approach
2.2.Data Sources
2.3.Assumptions & Limitations
Chapter 3. Executive Summary
3.1.Market Snapshot
Chapter 4. Market Variables and Scope
4.1.Introduction
4.2.Market Classification and Scope
4.3.Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5.COVID 19 Impact on Biopsy Devices Market
5.1. COVID-19 Landscape: Biopsy Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4.Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1.Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2.Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1.List of Suppliers
7.1.3.2.List of Buyers
Chapter 8. Global Biopsy Devices Market, By Product
8.1.Biopsy Devices Market, by Product Type, 2023-2032
8.1.1. Needle-based Biopsy Guns
8.1.1.1.Market Revenue and Forecast (2019-2032)
8.1.2. Biopsy Guidance Systems
8.1.2.1.Market Revenue and Forecast (2019-2032)
8.1.3. Biopsy Needles
8.1.3.1.Market Revenue and Forecast (2019-2032)
8.1.4. Biopsy Forceps
8.1.4.1.Market Revenue and Forecast (2019-2032)
8.1.5. Others
8.1.5.1.Market Revenue and Forecast (2019-2032)
Chapter 9. Global Biopsy Devices Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Product (2019-2032)
9.1.2. U.S.
9.1.2.1. Market Revenue and Forecast, by Product (2019-2032)
9.1.3. Rest of North America
9.1.3.1. Market Revenue and Forecast, by Product (2019-2032)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Product (2019-2032)
9.2.2. UK
9.2.2.1. Market Revenue and Forecast, by Product (2019-2032)
9.2.3. Germany
9.2.3.1. Market Revenue and Forecast, by Product (2019-2032)
9.2.4. France
9.2.4.1. Market Revenue and Forecast, by Product (2019-2032)
9.2.5. Rest of Europe
9.2.5.1. Market Revenue and Forecast, by Product (2019-2032)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Product (2019-2032)
9.3.2. India
9.3.2.1. Market Revenue and Forecast, by Product (2019-2032)
9.3.3. China
9.3.3.1. Market Revenue and Forecast, by Product (2019-2032)
9.3.4. Japan
9.3.4.1. Market Revenue and Forecast, by Product (2019-2032)
9.3.5. Rest of APAC
9.3.5.1. Market Revenue and Forecast, by Product (2019-2032)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Product (2019-2032)
9.4.2. GCC
9.4.2.1. Market Revenue and Forecast, by Product (2019-2032)
9.4.3. North Africa
9.4.3.1. Market Revenue and Forecast, by Product (2019-2032)
9.4.4. South Africa
9.4.4.1. Market Revenue and Forecast, by Product (2019-2032)
9.4.5. Rest of MEA
9.4.5.1. Market Revenue and Forecast, by Product (2019-2032)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Product (2019-2032)
9.5.2. Brazil
9.5.2.1. Market Revenue and Forecast, by Product (2019-2032)
9.5.3. Rest of LATAM
9.5.3.1. Market Revenue and Forecast, by Product (2019-2032)
Chapter 10.Company Profiles
10.1. Cardinal Health Inc.
10.1.1.Company Overview
10.1.2.Product Offerings
10.1.3.Financial Performance
10.1.4.Recent Initiatives
10.2. Hologic, Inc.
10.2.1.Company Overview
10.2.2.Product Offerings
10.2.3.Financial Performance
10.2.4.Recent Initiatives
10.3. Danaher Corporation
10.3.1.Company Overview
10.3.2.Product Offerings
10.3.3.Financial Performance
10.3.4.Recent Initiatives
10.4. CONMED Corporation
10.4.1.Company Overview
10.4.2.Product Offerings
10.4.3.Financial Performance
10.4.4.Recent Initiatives
10.5. Cook Medical
10.5.1.Company Overview
10.5.2.Product Offerings
10.5.3.Financial Performance
10.5.4.Recent Initiatives
10.6. DTR Medical
10.6.1.Company Overview
10.6.2.Product Offerings
10.6.3.Financial Performance
10.6.4.Recent Initiatives
10.7. INRAD, Inc.
10.7.1.Company Overview
10.7.2.Product Offerings
10.7.3.Financial Performance
10.7.4.Recent Initiatives
10.8. Devicor Medical Products Inc.
10.8.1.Company Overview
10.8.2.Product Offerings
10.8.3.Financial Performance
10.8.4.Recent Initiatives
10.9. Gallini Srl
10.9.1.Company Overview
10.9.2.Product Offerings
10.9.3.Financial Performance
10.9.4.Recent Initiatives
10.10. TransMed7, LLC
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11.Research Methodology
11.1.Primary Research
11.2.Secondary Research
11.3.Assumptions
Chapter 12.Appendix
12.1. About Us
12.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers